SCHEMBL4473038

SCHEMBL4473038

Cc1ccc(-c2ccccc2)c(-c2ccccc2)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP2 O95551 1/20 0.46
NSD2 O96028 1/20 0.46
HSP90AA1 P07900 1/20 0.46
PAX8 Q06710 1/20 0.46
ESR2 Q92731 1/20 0.45
CYP2A6 P11509 2/20 0.43
CYP2B6 P20813 1/20 0.43
PDCD1 Q15116 1/20 0.39
CD274 Q9NZQ7 1/20 0.39
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
CYP1A2 P05177 1/20 0.37
TSHR P16473 1/20 0.37
AKT2 P31751 2/20 0.36
CHEK1 O14757 1/20 0.36
AKT1 P31749 1/20 0.36
BRD4 O60885 1/20 0.36
BRD2 P25440 1/20 0.36
PARP10 Q53GL7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31276561 0.90 TDP2 (0.42) TDP2NSD2HSP90AA1PAX8ESR2
SCHEMBL30120609 0.89 TDP2 (0.42) TDP2NSD2HSP90AA1PAX8ESR2
SCHEMBL27744805 0.89 CYP1A2 (0.48) TDP2NSD2HSP90AA1PAX8ESR2
Phosphoric Acid SCHEMBL28543871 0.89 TDP2 (0.42) TDP2NSD2HSP90AA1PAX8ESR2
SCHEMBL10484543 0.86 PDCD1 (0.47) ESR2CYP2A6CYP2B6PDCD1CD274
SCHEMBL11573641 0.84 ESR2 (0.47) ESR2CYP2A6CYP2B6MAPTLMNA
SCHEMBL28235447 0.82 TDP2 (0.46) TDP2NSD2HSP90AA1PAX8PTGS1
SCHEMBL27902079 0.82 ESR2 (0.45) TDP2NSD2HSP90AA1PAX8ESR2
SCHEMBL30804714 0.81 ESR2 (0.48) TDP2NSD2HSP90AA1PAX8ESR2
SCHEMBL2400343 0.81 ESR2 (0.48) TDP2NSD2HSP90AA1PAX8ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103214341-A Method for synthesizing diarylmethane and triarylmethane in one step by using aromatic hydrocarbon and benzyl halid UNIV CHONGQING 2013-07-24 CN claimed
US-5110500-A Polysiloxane scintillator composition UNIVERSITY OF FLORIDA (US) 1992-05-05 US claimed
EP-0358413-A1 Polysiloxane scintillator composition THE UNIVERSITY OF FLORIDA (US) 1990-03-14 EP claimed
US-20250270393-A1 COMPOSITIONS FOR ELASTOMERIC COMPOUNDS COMPRSING FUNCTIONALISED DIENE POLYMERS AND TYRES COMPRISING THE SAME PIRELLI TYRE S.P.A. (IT) 2025-08-28 US disclosed
EP-4363238-A1 COMPOSITIONS FOR ELASTOMERIC COMPOUNDS COMPRISING FUNCTIONALISED DIENE POLYMERS AND TYRES COMPRISING THE SAME Pirelli Tyre S.P.A. (IT) 2024-05-08 EP disclosed
CN-117044428-A Lateral current suppressing material, carbazole compound, hole injection layer, and organic electroluminescent element 东曹株式会社 2023-11-10 CN disclosed
WO-2023275783-A9 COMPOSITIONS FOR ELASTOMERIC COMPOUNDS COMPRISING FUNCTIONALISED DIENE POLYMERS AND TYRES COMPRISING THE SAME PIRELLI TYRE S.P.A. (IT) 2023-03-02 WO disclosed
WO-2023275783-A1 COMPOSITIONS FOR ELASTOMERIC COMPOUNDS COMPRISING FUNCTIONALISED DIENE POLYMERS AND TYRES COMPRISING THE SAME PIRELLI TYRE S.P.A. (IT) 2023-01-05 WO disclosed
US-10749176-B2 Cathode active material used for lithium ion secondary battery, method for producing same, and lithium ion secondary battery HITACHI METALS, LTD. (JP) 2020-08-18 US disclosed
US-20190006670-A1 CATHODE ACTIVE MATERIAL USED FOR LITHIUM ION SECONDARY BATTERY, METHOD FOR PRODUCING SAME, AND LITHIUM ION SECONDARY BATTERY HITACHI METALS, LTD. (JP) 2019-01-03 US disclosed
US-20180226678-A1 Non-Aqueous Electrolyte Solution Used for Lithium Secondary Battery, Cathode Used for Lithium Secondary Battery and Method for Producing the Same, and Lithium Secondary Battery HITACHI HIGH-TECHNOLOGIES CORPORATION (JP) 2018-08-09 US disclosed
US-20040175328-A1 Spray-dried microparticles and their use as therapeutic vehicles QUADRANT DRUG DELIVERY LIMITED (GB) 2004-09-09 US disclosed
US-6709650-B1 PULMONARY AIRWAYS MUCOSAL TRANSFER DELIVERY OF PEPTIDES ELAM DRUG DELIVERY LIMITED (GB) 2004-03-23 US disclosed
US-20030060591-A1 Heat-resistant polyether, curable polyether, and coating liquid for forming a polyether film SUMITOMO CHEMICAL COMPANY, LIMITED 2003-03-27 US disclosed
US-5993805-A Spray-dried microparticles and their use as therapeutic vehicles QUADRANT HEALTHCARE (UK) LIMITED (GB) 1999-11-30 US disclosed
EP-0783298-A1 SPRAY-DRIED MICROPARTICLES AS THERAPEUTIC VEHICLES Andaris Limited (GB) 1997-07-16 EP disclosed
WO-1996009814-A1 SPRAY-DRIED MICROPARTICLES AS THERAPEUTIC VEHICLES ANDARIS LIMITED (GB) 1996-04-04 WO disclosed
CN-1029005-C Method for synthesizing dielectric liquid ATOCHEM (FR) 1995-06-21 CN disclosed
US-5110500-A Polysiloxane scintillator composition UNIVERSITY OF FLORIDA (US) 1992-05-05 US disclosed
CN-1050894-A The preparation method of the synthesis of dielectric fluids ATOCHEM (FR) 1991-04-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030060591-A1 Heat-resistant polyether, curable polyether, and coating liquid for forming a polyether film HEATR1, HSP90AA1, HEATR6 TDP2 3877/4885NSD2 3086/4885HSP90AA1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.